ranibizumab
Lucentis (Anti-VEGF)
Plain-language definition
An anti-VEGF antibody fragment injected into the eye for wet AMD, diabetic macular edema, and retinal vein occlusions. Brand name: Lucentis.
Where this term comes up
“Ranibizumab (Lucentis)”
Treatment · Intravitreal Injection
“Ranibizumab (Lucentis)”
Condition · Wet Age-Related Macular Degeneration (Wet AMD)
“Ranibizumab (Lucentis)”
Condition · Diabetic Macular Edema (DME)
- Category
- Medication
- Also written as
- No alternate forms listed.
Medication terms describe drugs or drug classes that may be used in eye care, neurology, inflammation, infection, or pain treatment.
Related glossary terms
- anti-VEGF
Anti-Vascular Endothelial Growth Factor
- macula
Central Retina
- bevacizumab
Avastin (Off-Label Anti-VEGF)
- aflibercept
Eylea (Anti-VEGF)
- hemorrhage
Bleeding
- neovascularization
Abnormal New Vessel Growth
A note on medical context
A glossary definition can explain a word, but it cannot tell you whether a symptom or test result is serious. If this term came from an article, use the full article and your clinician's guidance for context.